Smart drugs fall short of cognitive enhancers
Recently, there has been an increase in the use of prescription stimulant drugs by students and employees to increase their academic and work productivity. While these drugs have been perceived…
Pharma giant could lose payment of $1.7 billion opioid deal as deal threatens to fall apart
The 125-year-old pharmaceutical giant behind morphine and codeine owes $200 million by the end of the day Friday to an opioid victim compensation fund and could reportedly renege on payment…